参麦注射液与丹参注射液治疗社区冠心病的临床观察

摘要

目的对比冠心病患者采用丹参注射液、参麦注射液进行临床治疗的有效性。方法抽取我市某社区2011年8月~2014年8月收治的30例冠心病患者作为研究对象，分成观察组与对照组，对照组采用丹参注射液进行治疗，观察组采用参麦注射液进行治疗，对比两组患者治疗效果。结果观察组与对照组总有效率分别为86.66%、60.00%，观察组总有效率明显高于对照组（<0.05）；观察组治疗后纤维蛋白原为（2.82±0.81），血浆比粘度为（1.48±0.11），相对比对照组来说，观察组具有明显降低，组间数据对比有统计学意义（<0.05）。结论参麦注射液用于冠心病患者的临床治疗中获得的治疗效果明显优于丹参注射液，对改善患者治疗预后具有非常重要的意义。%Objective To compare coronary heart disease were treated by salvia miltiorrhiza injection,and the effectiveness of injection for clinical treatment.Methods To extract the city a certain community in August 2011 to August 2014 were 30 cases of coronary heart disease patients as the research object,is divided into observation group and control group,control group adopts the salvia miltiorrhiza injection treatment,observation group adopt injection treatment,compared two groups of patients with therapeutic effect.Results Observation group and control group total effective rate were 86.66%,60.00%,total effective observation group was obviously higher than that of control group( <0.05);Observation group originally fibrin(2.82±0.81) after treatment,plasma specific viscosity(1.48±0.11),the relative than the control group,the observation group is significantly lower,contrast between the data set was statistically significant ( <0.05).Conclusion Ginseng injection for the treatment of clinical treatment in patients with coronary heart disease (CHD)in effect is obviously better than that of salvia miltiorrhiza injection,has very important significance for improving the prognosis of patients.